Alemtuzumab (CAMPATH 1H) Induction Therapy in Cadaveric Kidney Transplantation-Efficacy and Safety at Five Years-Reference-Cited by-同舟云学术

Alemtuzumab (CAMPATH 1H) Induction Therapy in Cadaveric Kidney Transplantation-Efficacy and Safety at Five Years

Published:2005-06 Issue:6 Volume:5 Page:1347-1353
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Watson Christopher J. E.,Bradley J. Andrew,Friend Peter J.,Firth John,Taylor Craig J.,Bradley John R.,Smith Kenneth G. C.,Thiru Sathia,Jamieson Neville V.,Hale Geoff,Waldmann Herman,Calne Roy

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2005.00822.x/fullpdf

Reference24 articles.

1. From Laboratory to Clinic

2. Pharmacokinetics of CAMPATH-1H in BMT patients

3. Campath-1H (Anti-CD52) Monoclonal Antibody Therapy in Lymphoproliferative Disorders

4. Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study

5. Treatment of active refractory rheumatoid arthritis with humanized monoclonal antibody campath-1h administered by daily subcutaneous injection

Cited by 202 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoclonal Antibodies in Solid Organ Transplantation;Pharmaceutical Biotechnology;2024

2. Therapy in the Course of Kidney Graft Rejection—Implications for the Cardiovascular System—A Systematic Review;Life;2023-06-27

3. Induction Therapy in Pediatric Renal Transplant Recipients;Pediatric Solid Organ Transplantation;2023

4. Solid Organ Transplantation: Rejection, Immunosuppression, and Tolerance;Clinical Immunology;2023

5. Immunosuppression Therapy in Kidney Transplantation;Urologic Clinics of North America;2022-05